EGFR and glioblastoma: Fourteen out of 43 articles (including 2265 patients) assessed EGFR or epidermal growth factor receptor variant III (EGFRvIII) status in GBM patients [77,81,82,83,86,89,90,92,95,96,97,101,103,106].